IMR Press / EJGO / Volume 9 / Issue 1 / pii/1988009

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Original Research

Total LDH and its isoenzymes in gynecological malignancies and other gynecological conditions

Show Less
1 Obstetrics and Gynecology, Hospital Clinic, University of Barcelona School of Medicine, Barcelona, Spagna
2 Central Laboratory, Hospital Clinic, University of Barcelona School of Medicine, Barcelona, Spagna
3 Department, and Department of Biostatistics, Hospital Clinic, University of Barcelona School of Medicine, Barcelona, Spagna
Eur. J. Gynaecol. Oncol. 1988, 9(1), 32–35;
Published: 10 February 1988
Abstract

Total LDH and its five Isoenzymes have been evaluated in 354 patients from a Gynecological Ward. These patients had uterine fibroids, benign ovarian tumors, tuba-ovarian abscesses (T.O.A.), endometrial cancers, cancers of the cervix and ovarian cancers. 90 patients had no gynecological disease and served as controls. A statistical analysis was performed comparing each group of patients with the control group. A significant elevation in total LDH and Iso-IV and a significant decrease in Iso-I was observed in patients with uterine fibroids. Patients with benign ovarian tumors had a significant elevation of total LDH. Patients with T.O.A., Endometrial cancer, cancer of the cervix and cancer of the ovary had a significant elevations of total LDH and Iso-V and a significant decrease in Iso-I. When the group of patients with endometrial cancer, cancer of the cervix and cancer of the ovary were compared with each other, no differences could be found in total LDH and Isoenzyme values. We conclude that total LDH and Isoenzyme serum levels are not useful clinical indicators for the diagnosis and management of gynecological malignancies and particularly of ovarian cancer.

Share
Back to top